(From left to right) Peter Menziuso, Company Group Chairman, Johnson & Johnson Vision, Vaibhav Saran, Area Vice President, APAC, Vision Care, Johnson & Johnson Vision, Dr Su Yi, Executive Director of A*STAR’s, Institute of High Performance Computing, and Professor Tan Sze Wee, Assistant Chief Executive of Enterprise, A*STAR, at the signing of the MoU, on Jul 12, 2022, marking the joint establishment of the Eye Health Digital Innovation Consortium.
J&J, A*Star invest $15m for eye health digital innovation consortium
The consortium will create projects for trusted data access in eye care.
Two firms invested over $15m to launch an eye health digital innovation consortium, which will advance eye health research and address rising optical needs in the Asia Pacific region.
The consortium stemmed from a memorandum of understanding between Johnson & Johnson VisionCare (J&J) and the Singapore Agency for Science, Technology, and Research (A*STAR).
In a joint statement, both firms will ink public-private partnerships between eye care professionals (ECPs), academe, and the industry for innovations. The joint investment will also take over three years.
Amongst the three new projects lined up for the consortium are MyoABank, which is a digital consent management platform that will consolidate data for eye health studies, behaviourally-informed messages to enhance eye health, and e-referral and e-triaging to step-up and step-down eye care in communities.
These projects will develop data-centric research and innovative technologies including AI, blockchain, data privacy preservation techniques, and personal data compliance for trusted data access and sharing relationships between patients, ECPs, researchers, clinical practitioners, and public health policymakers.
Read Here
Advertise
Sign Up
